BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 19294860)

  • 21. Apoptosis induction by (+)alpha-tocopheryl succinate in the absence or presence of all-trans retinoic acid and arsenic trioxide in NB4, NB4-R2 and primary APL cells.
    Freitas RA; Silva dos Santos GA; Gimenes Teixeira HL; Scheucher PS; Lucena-Araujo AR; Lima AS; Abreu e Lima RS; Garcia AB; Jordão AA; Falcão RP; Vannucchi H; Rego EM
    Leuk Res; 2009 Jul; 33(7):958-63. PubMed ID: 19013639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Molecular mechanism of tetramethylpyrazine to induce human promyelocytic HL-60 leukemia cells differentiation].
    Wu Y; Xu Y; Gu X; Hu Y; Wang C
    Zhongguo Zhong Yao Za Zhi; 2011 Nov; 36(21):3007-11. PubMed ID: 22308692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Notch ligand, Delta-1, alters retinoic acid (RA)-induced neutrophilic differentiation into monocytic and reduces RA-induced apoptosis in NB4 cells.
    Murata-Ohsawa M; Tohda S; Kogoshi H; Sakano S; Nara N
    Leuk Res; 2005 Feb; 29(2):197-203. PubMed ID: 15607369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene expression analysis of human promyelocytic leukemia HL-60 cell differentiation and cytotoxicity induced by natural and synthetic retinoids.
    Wang J; Fong CC; Tzang CH; Xiao P; Han R; Yang M
    Life Sci; 2009 Apr; 84(17-18):576-83. PubMed ID: 19302803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The bioactive lipid sphingosylphosphorylcholine induces differentiation of mouse embryonic stem cells and human promyelocytic leukaemia cells.
    Kleger A; Busch T; Liebau S; Prelle K; Paschke S; Beil M; Rolletschek A; Wobus A; Wolf E; Adler G; Seufferlein T
    Cell Signal; 2007 Feb; 19(2):367-77. PubMed ID: 16978842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FUS expression alters the differentiation response to all-trans retinoic acid in NB4 and NB4R2 cells.
    Walsby EJ; Gilkes AF; Tonks A; Darley RL; Mills KI
    Br J Haematol; 2007 Oct; 139(1):94-7. PubMed ID: 17854312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study on the relationship between NB4 cell apoptosis induced by tanshinone IIA and the cell mitochondrial transmembrane potential.
    Meng W; Yang Y; Deng C; Liu T; Jia Y
    Zhonghua Xue Ye Xue Za Zhi; 2002 Jun; 23(6):297-300. PubMed ID: 12411059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nucleoside transporter expression and activity is regulated during granulocytic differentiation of NB4 cells in response to all-trans-retinoic acid.
    Flanagan SA; Meckling KA
    Leuk Res; 2007 Jul; 31(7):955-68. PubMed ID: 17045336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C/EBPβ and CHOP participate in tanshinone IIA-induced differentiation and apoptosis of acute promyelocytic leukemia cells in vitro.
    Zhang K; Li J; Meng W; Xing H; Yang Y
    Int J Hematol; 2010 Nov; 92(4):571-8. PubMed ID: 20981511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ICAT as a potential enhancer of monocytic differentiation: implications from the comparative proteome analysis of the HL60 cell line stimulated by all-trans retinoic acid and NSC67657.
    Wang W; Zhang X; Deng K; Huang S; Mao X; Fu Y; Yi Z; Yan Y; Qiu Z
    Cell Biochem Funct; 2009 Aug; 27(6):329-37. PubMed ID: 19569129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth inhibition and apoptosis induction by tanshinone IIA in human colon adenocarcinoma cells.
    Su CC; Chen GW; Kang JC; Chan MH
    Planta Med; 2008 Sep; 74(11):1357-62. PubMed ID: 18622903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct effects of different concentrations of sodium selenite on apoptosis, cell cycle, and gene expression profile in acute promyeloytic leukemia-derived NB4 cells.
    Cao TM; Hua FY; Xu CM; Han BS; Dong H; Zuo L; Wang X; Yang Y; Pan HZ; Zhang ZN
    Ann Hematol; 2006 Jul; 85(7):434-42. PubMed ID: 16705456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Terminal differentiation of human acute promyelocytic leukemia (APL) cells induced by Tanshinone II A in primary culture].
    Liang Y; Yang Y; Yuan S; Liu T; Jia Y; Xu C; Niu T; Qin H; Qin P
    Hua Xi Yi Ke Da Xue Xue Bao; 2000 Jun; 31(2):207-10. PubMed ID: 12515138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Anticancer effect of tanshinone and its mechanisms].
    Yuan SL; Wang XJ; Wei YQ
    Ai Zheng; 2003 Dec; 22(12):1363-6. PubMed ID: 14693071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maturation sensitive and resistant t(15;17) NB4 cell lines as tools for APL physiopathology: nomenclature of cells and repertory of their known genetic alterations and phenotypes.
    Roussel MJ; Lanotte M
    Oncogene; 2001 Oct; 20(49):7287-91. PubMed ID: 11704857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IRF-9/STAT2 [corrected] functional interaction drives retinoic acid-induced gene G expression independently of STAT1.
    Lou YJ; Pan XR; Jia PM; Li D; Xiao S; Zhang ZL; Chen SJ; Chen Z; Tong JH
    Cancer Res; 2009 Apr; 69(8):3673-80. PubMed ID: 19351818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acrylamide-induced molecular mutation spectra at HPRT locus in human promyelocytic leukaemia HL-60 and NB4 cell lines.
    Ao L; Liu SX; Yang MS; Fong CC; An H; Cao J
    Mutagenesis; 2008 Jul; 23(4):309-15. PubMed ID: 18407966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tanshinone IIA suppresses inflammatory bone loss by inhibiting the synthesis of prostaglandin E2 in osteoblasts.
    Kwak HB; Sun HM; Ha H; Kim HN; Lee JH; Kim HH; Shin HI; Lee ZH
    Eur J Pharmacol; 2008 Dec; 601(1-3):30-7. PubMed ID: 18973753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Anti-tumor effect of tanshinone II A, tetrandrine, honokiol, curcumin, oridonin and paeonol on leukemia cell lines].
    Shan QQ; Gong YP; Guo Y; Lin J; Zhou RQ; Yang X
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 May; 43(3):362-6. PubMed ID: 22812238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of tanshinone IIA on the hepatotoxicity and gene expression involved in alcoholic liver disease.
    Yin HQ; Kim YS; Choi YJ; Kim YC; Sohn DH; Ryu SY; Lee BH
    Arch Pharm Res; 2008 May; 31(5):659-65. PubMed ID: 18481025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.